For the Inventor, By the Inventor

Enter assignee name

Wokingham, United Kingdom

Vernalis Research Limited

USPTO Granted Patents = 43

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 256

Loading Chart...

Loading Chart...

55 inventors (with patents filed for the assignee):

David Reginald Adams (20 out of 20 patents)

Roger John Gillespie (16 out of 25 patents)

Howard Langham Mansell (15 out of 16 patents)

4. Jonathan Richard Anthony Roffey (14 out of 14 patents)

5. Joanne Lerpiniere (12 out of 12 patents)

6. James Edward Paul Davidson (12 out of 13 patents)

7. Suneel Gaur (11 out of 11 patents)

8. Richard John Hamlyn (11 out of 11 patents)

9. Jonathan Mark Bentley (10 out of 13 patents)

10. Claire Elizabeth Dawson (8 out of 8 patents)

11. Stephan Roever (7 out of 56 patents)

12. Nathaniel Monck (7 out of 7 patents)

13. Ian Anthony Cliffe (7 out of 7 patents)

14. Paul Hebeisen (6 out of 49 patents)

15. Robert Mark Pratt (6 out of 6 patents)

Core Competencies:

Purinergic Receptor Antagonists

5HT2C Receptor Agonists

Anti-Obesity Compounds

Indole Derivatives

CNS Disorder Treatments

Glutamatergic Transmission

A2A-Receptor Antagonists

Pyrimidine Derivatives

Morpholine Derivatives

Triazolo Derivatives

Azetidinecarboxamide Derivatives

Hexahydropyrazinoindoles

43 patents: Sort by Forward Citations

1. 7629349 - Pyrazolo [3,4-d] pyrimidine derivatives and their use as purinergic receptor antagonists (2009-12-08),

2. 7598256 - Pyrrolo [2,3-d] pyrimidine and their use as purinergic receptor antagonists (2009-10-06),

3. 7589097 - Triazol[4,5-d] pyramidine derivatives and their use as purinergic receptor antagonists (2009-09-15),

4. 7547699 - Tetracyclic 6 azapyrazinoindolines as 5HT2C receptor agonists for obesity (2009-06-16),

5. 7504522 - Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders (2009-03-17),

6. 7452894 - Purine derivatives as purinergic receptor antagonists (2008-11-18),

7. 7405219 - Triazolo [4,5-d] pyrimidine derivatives and their use as purinergic receptor antagonists (2008-07-29),

8. 7384949 - Thieno(3,2-d)pyrimidines and furano(3,2-d)pyrimidines and their use as purinergic receptor antagonists (2008-06-10),

9. 7323487 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2008-01-29),

10. 7323486 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2008-01-29),

11. 7323473 - [object Object] (2008-01-29),

12. 7323466 - Morpholine derivatives as 5HT2C receptor agonists for the treatment of obesity (2008-01-29),

13. 7253281 - Anti-obesity 1,2,3,4,10,10a-hexahydropyrazino[1,2-a]indoles (2007-08-07),

14. 7208494 - 5HT2c receptor agonists (2007-04-24),

15. 7173056 - Condensed indoline derivatives and their use as 5HT, in particular 5HT2C, receptor ligands (2007-02-06),

Vernalis Research Limited is a leading drug discovery and development company, specializing in the development of innovative pharmaceuticals. They focus on the discovery of small molecules for various therapeutic areas, including oncology, neurology, and infectious diseases. With a strong scientific team and state-of-the-art facilities, Vernalis Research Limited is dedicated to delivering high-quality, effective treatments to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

43 Patents

#1 in Wokingham

#392 in United Kingdom

#15,579 in the World

Wokingham, United Kingdom

Vernalis Research Limited

Forward Citations = 256

55 inventors:

David Reginald Adams (20 out of 20 patents)

Roger John Gillespie (16 out of 25 patents)

Howard Langham Mansell (15 out of 16 patents)

4. Jonathan Richard Anthony Roffey (14 out of 14 patents)

5. Joanne Lerpiniere (12 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…